80% of SOLIQUA 44 Units = 35.2 Units
When converting from a 44-unit dose of SOLIQUA 100/33 to 80% of that dose, administer 35.2 units (round to 35 units in clinical practice).
Understanding SOLIQUA Dosing
SOLIQUA 100/33 is a fixed-ratio combination product containing:
- 100 units/mL of insulin glargine
- 33 mcg/mL of lixisenatide
This means each unit of SOLIQUA delivers both 1 unit of insulin glargine AND 0.33 mcg of lixisenatide simultaneously 1.
The 80% Dose Reduction Context
The 80% dose reduction principle appears in multiple clinical scenarios in the diabetes guidelines:
When Converting NPH Insulin Regimens
When transitioning from bedtime NPH to twice-daily NPH or to a basal-bolus regimen, the total NPH dose should be reduced to 80% of the current dose 2, 3. This reduction helps prevent hypoglycemia during regimen intensification.
Application to SOLIQUA
For your specific calculation with SOLIQUA:
- Starting dose: 44 units
- 80% of 44 units: 44 × 0.80 = 35.2 units
- Practical dose: Round to 35 units
Clinical Context for Dose Reductions
Common scenarios requiring dose reduction to 80%:
- Transitioning insulin regimens to prevent hypoglycemia during the adjustment period 2
- Converting from bedtime to split-dose regimens where insulin distribution changes 3
- Adding prandial insulin when A1C is <8% (<64 mmol/mol), consider lowering basal by 10% or 4 units 2
Important Caveats
Monitor closely after any dose reduction:
- Check fasting plasma glucose to ensure adequate basal coverage
- Assess for hyperglycemia that may require dose re-escalation
- For hypoglycemia without clear cause, reduce dose by 10-20% 2
SOLIQUA-specific considerations: